Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 714

1.

Decade in review-HCV: Hepatitis C therapy-a fast and competitive race.

Zeuzem S.

Nat Rev Gastroenterol Hepatol. 2014 Sep 16. doi: 10.1038/nrgastro.2014.164. [Epub ahead of print] No abstract available.

PMID:
25223875
[PubMed - as supplied by publisher]
2.

Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients.

van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, Zeuzem S, Lawitz EJ, Rodriguez-Torres M, Kupcova V, Wiercinska-Drapalo A, Hodges MR, Janssen HL, Reesink HW.

Antiviral Res. 2014 Sep 8. pii: S0166-3542(14)00252-6. doi: 10.1016/j.antiviral.2014.08.015. [Epub ahead of print]

PMID:
25218783
[PubMed - as supplied by publisher]
3.

A novel, stiff-shaft, flexible-tip guidewire for cannulation of biliary stricture during endoscopic retrograde cholangiopancreatography: a randomized trial.

Albert JG, Lucas K, Filmann N, Herrmann E, Schröder O, Sarrazin C, Trojan J, Kronenberger B, Bojunga J, Zeuzem S, Friedrich-Rust M.

Endoscopy. 2014 Sep 10. [Epub ahead of print]

PMID:
25208030
[PubMed - as supplied by publisher]
4.

Soluble CD163 is an indicator of liver inflammation and fibrosis in patients chronically infected with the hepatitis B virus.

Dultz G, Gerber L, Farnik H, Berger A, Vermehren J, Pleli T, Zeuzem S, Piiper A, Kronenberger B, Waidmann O.

J Viral Hepat. 2014 Sep 2. doi: 10.1111/jvh.12309. [Epub ahead of print]

PMID:
25181653
[PubMed - as supplied by publisher]
5.

Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.

Scott J, Rosa K, Fu M, Cerri K, Peeters M, Beumont M, Zeuzem S, Evon DM, Gilles L.

BMC Infect Dis. 2014 Aug 26;14(1):465. doi: 10.1186/1471-2334-14-465.

PMID:
25164700
[PubMed - in process]
Free PMC Article
6.

[Prof. Dr. med. Peter Galle].

Zeuzem S.

Z Gastroenterol. 2014 Aug;52(8):799-800. doi: 10.1055/s-0034-1366693. Epub 2014 Aug 11. German. No abstract available.

PMID:
25111717
[PubMed - in process]
7.

Polymorphisms of HLA-DP are associated with response to peginterferon in Caucasian patients with chronic hepatitis B.

Brouwer WP, Sonneveld MJ, Tabak F, Simon K, Cakaloglu Y, Akarca US, Zeuzem S, Ferenci P, Heathcote JE, de Knegt RJ, Boonstra A, Hansen BE, Janssen HL.

Aliment Pharmacol Ther. 2014 Oct;40(7):811-8. doi: 10.1111/apt.12910. Epub 2014 Aug 11.

PMID:
25109699
[PubMed - in process]
8.

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study.

Hézode C, Hirschfield GM, Ghesquiere W, Sievert W, Rodriguez-Torres M, Shafran SD, Thuluvath PJ, Tatum HA, Waked I, Esmat G, Lawitz EJ, Rustgi VK, Pol S, Weis N, Pockros PJ, Bourlière M, Serfaty L, Vierling JM, Fried MW, Weiland O, Brunetto MR, Everson GT, Zeuzem S, Kwo PY, Sulkowski M, Bräu N, Hernandez D, McPhee F, Wind-Rotolo M, Liu Z, Noviello S, Hughes EA, Yin PD, Schnittman S.

Gut. 2014 Jul 30. pii: gutjnl-2014-307498. doi: 10.1136/gutjnl-2014-307498. [Epub ahead of print]

PMID:
25080450
[PubMed - as supplied by publisher]
9.

Anti-HDV IgM as a marker of disease activity in hepatitis delta.

Wranke A, Heidrich B, Ernst S, Calle Serrano B, Caruntu FA, Curescu MG, Yalcin K, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Bremer B, Stift J, Grabowski J, Kirschner J, Port K, Cornberg M, Falk CS, Dienes HP, Hardtke S, Manns MP, Yurdaydin C, Wedemeyer H; HIDIT-2 Study Group.

PLoS One. 2014 Jul 29;9(7):e101002. doi: 10.1371/journal.pone.0101002. eCollection 2014.

PMID:
25072849
[PubMed - in process]
Free PMC Article
10.

A Randomized Phase 2b Study of Peginterferon Lambda-1a for the Treatment of Chronic HCV Infection.

Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S; for the EMERGE study group.

J Hepatol. 2014 Jul 23. pii: S0168-8278(14)00521-2. doi: 10.1016/j.jhep.2014.07.022. [Epub ahead of print]

PMID:
25064437
[PubMed - as supplied by publisher]
11.

Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study.

Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S, Ferreirós N, Zeuzem S, Piiper A, Waidmann O.

PLoS One. 2014 Jul 25;9(7):e103532. doi: 10.1371/journal.pone.0103532. eCollection 2014.

PMID:
25062038
[PubMed - in process]
Free PMC Article
12.

Kinetics of hepatitis B surface antigen loss in patients with HBeAg-positive chronic hepatitis B treated with tenofovir disoproxil fumarate.

Marcellin P, Buti M, Krastev Z, de Man RA, Zeuzem S, Lou L, Gaggar A, Flaherty JF, Massetto B, Lin L, Dinh P, Mani Subramanian G, McHutchison JG, Flisiak R, Gurel S, Dusheiko GM, Jenny Heathcote E.

J Hepatol. 2014 Jul 18. pii: S0168-8278(14)00518-2. doi: 10.1016/j.jhep.2014.07.019. [Epub ahead of print]

PMID:
25046847
[PubMed - as supplied by publisher]
13.

Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late.

Pellicelli AM, Montalbano M, Lionetti R, Durand C, Ferenci P, D'Offizi G, Knop V, Telese A, Lenci I, Andreoli A, Zeuzem S, Angelico M.

Dig Liver Dis. 2014 Oct;46(10):923-7. doi: 10.1016/j.dld.2014.06.004. Epub 2014 Jul 3.

PMID:
24997638
[PubMed - in process]
14.

[In Process Citation].

Hézode C, Brainard D, Pol S, Libert O, Symondq W, McHutchison J, Zeuzem S.

Med Mal Infect. 2014 Jun;44(6 Suppl):1. doi: 10.1016/S0399-077X(14)70040-X. French. No abstract available.

PMID:
24994127
[PubMed - in process]
15.

Multi-center proficiency tests for Lab-MELD score diagnostics to improve the quality and safety for patients awaiting liver transplantation.

Kaiser T, Zeuzem S, Lichtinghagen R, Welker MW, Geilenkeuser WJ, Kruse R, Neumaier M, Thiery J, Schmidt M.

Clin Chem Lab Med. 2014 Jun 24. pii: /j/cclm.ahead-of-print/cclm-2014-0088/cclm-2014-0088.xml. doi: 10.1515/cclm-2014-0088. [Epub ahead of print] No abstract available.

PMID:
24960153
[PubMed - as supplied by publisher]
16.

Feasibility of global miRNA analysis from fine-needle biopsy FFPE material in patients with hepatocellular carcinoma treated with sorafenib.

Peveling-Oberhag J, Döring C, Hartmann S, Filmann N, Mertens A, Piiper A, Herrmann E, Hansmann ML, Zeuzem S, Trojan J, Welker MW.

Clin Sci (Lond). 2015 Jan 1;128(1):29-37. doi: 10.1042/CS20140007.

PMID:
24959956
[PubMed - in process]
17.

Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.

Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V; CANONIC study investigators of the EASL-CLIF Consortium.

J Hepatol. 2014 Jun 17. pii: S0168-8278(14)00408-5. doi: 10.1016/j.jhep.2014.06.012. [Epub ahead of print]

PMID:
24950482
[PubMed - as supplied by publisher]
18.

The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis.

Grammatikos G, Farnik H, Bon D, Böhlig A, Bader T, Berg T, Zeuzem S, Herrmann E.

J Viral Hepat. 2014 Aug;21(8):533-41. doi: 10.1111/jvh.12274. Epub 2014 Jun 18.

PMID:
24943517
[PubMed - in process]
19.

Rejection quantity in kidney transplant recipients is associated with increasing intracellular interleukin-2 in CD8+ T-cells.

Akoglu B, Lafferton B, Kalb S, Yosuf SE, Herrmann E, Zeuzem S, Goßmann J, Kachel HG, Scheuermann EH, Faust D.

Transpl Immunol. 2014 Jun;31(1):17-21. doi: 10.1016/j.trim.2014.05.004. Epub 2014 Jun 2.

PMID:
24887424
[PubMed - in process]
20.

The capsule endoscopy "suspected blood indicator" (SBI) for detection of active small bowel bleeding: no active bleeding in case of negative SBI.

Tal AO, Filmann N, Makhlin K, Hausmann J, Friedrich-Rust M, Herrmann E, Zeuzem S, Albert JG.

Scand J Gastroenterol. 2014 Sep;49(9):1131-5. doi: 10.3109/00365521.2014.923503. Epub 2014 Jun 2.

PMID:
24884306
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk